UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Clinical cancer research, 2008-01, Vol.14 (1), p.155-161

2008

Volltextzugriff (PDF)

Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation‐Wide cohort study

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.6536-6546

2023

Volltextzugriff (PDF)

Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy

British journal of haematology, 2016-09, Vol.174 (6), p.859-867

2016

Volltextzugriff (PDF)

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Blood, 2006-07, Vol.108 (1), p.177-183

2006

Volltextzugriff (PDF)

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

European journal of haematology, 2010-10, Vol.85 (4), p.321-328

2010

Volltextzugriff (PDF)

Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma

Cancer medicine (Malden, MA), 2017-11, Vol.6 (11), p.2507-2514

2017

Volltextzugriff (PDF)

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Blood, 2007-05, Vol.109 (10), p.4258-4263

2007

Volltextzugriff (PDF)

Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial

British journal of haematology, 2014-11, Vol.167 (3), p.327-336

2014

Volltextzugriff (PDF)

A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients

American journal of hematology, 2016-06, Vol.91 (6), p.E305-E307

2016

Volltextzugriff (PDF)

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Oncotarget, 2016-03, Vol.7 (9), p.10174-10181

2016

Volltextzugriff (PDF)

Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: Influence of geographical factors and occupational exposure

Molecular carcinogenesis, 2012-06, Vol.51 (6), p.508-513

2012

Volltextzugriff (PDF)

Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings

Transfusion and apheresis science, 2007-06, Vol.36 (3), p.235-242

2007

Volltextzugriff (PDF)

Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

British journal of haematology, 2002-08, Vol.118 (2), p.610-614

2002

Volltextzugriff (PDF)

Protein Z‐dependent protease inhibitor W303X mutation in venous thrombosis

British journal of haematology, 2005-05, Vol.129 (4), p.561-562

2005

Volltextzugriff (PDF)

Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas

Annals of hematology, 2014-02, Vol.93 (2), p.243-247

2014

Volltextzugriff (PDF)

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma

European journal of haematology, 2016-05, Vol.96 (5), p.532-540

2016

Volltextzugriff (PDF)

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study

BMC cancer, 2013-05, Vol.13 (1), p.228-228, Article 228

2013

Volltextzugriff (PDF)

L-Asparaginase-Induced Antithrombin Type I Deficiency: Implications for Conformational Diseases

The American journal of pathology, 2006-07, Vol.169 (1), p.142-153

2006

Volltextzugriff (PDF)

Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methods

Transfusion (Philadelphia, Pa.), 2003-12, Vol.43 (12), p.1723-1728

2003

Volltextzugriff (PDF)

Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger

Pharmacogenetics and genomics, 2017-02, Vol.27 (2), p.70-77

2017

Volltextzugriff (PDF)

Hiper CVAD Followed by Rituximab Purging Previous to Autologous Stem-Cell Transplantation as Therapy of Mantle Cell Lymphoma. Results of Manto 2000 study

Blood, 2009-11, Vol.114 (22), p.931-931

2009

Volltextzugriff (PDF)

Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia

Blood, 2009-11, Vol.114 (22), p.3194-3194

2009

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(22)
Hematology
(17)
Male
(17)
Female
(15)
Middle Aged
(15)
Adult
(11)
Aged
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Oncology
(9)
Lymphoma
(8)
Risk Factors
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Hematologic And Hematopoietic Diseases
(5)
Polymorphism
(5)
Rituximab
(5)
Treatment Outcome
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation‐Wide cohort study

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma

The role of bone marrow biopsy and FDG‐PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non‐Hodgkin B‐cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial

A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: Influence of geographical factors and occupational exposure

Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings

Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

Protein Z‐dependent protease inhibitor W303X mutation in venous thrombosis

Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study

L-Asparaginase-Induced Antithrombin Type I Deficiency: Implications for Conformational Diseases

Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methods

Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger

Hiper CVAD Followed by Rituximab Purging Previous to Autologous Stem-Cell Transplantation as Therapy of Mantle Cell Lymphoma. Results of Manto 2000 study

Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia

Suchergebnisse filtern